NET SALES (Tables)

9 Months Ended

Sep. 30, 2025

Revenue from Contract with Customer [Abstract]

SCHEDULE OF NET SALES BY MARKET

The following tables summarize our net sales by market for the three and nine months ended September 30, 2025 and 2024, respectively:

	Three Months Ended September 30, 2025
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration1		Total Net Sales by Market
Medical Device	$	5,758	$	2,004	$	589	$	8,351
Medical Imaging		8,215		2,169		5		10,389
Industrial		6,163		1,798		251		8,212
Aerospace and Defense		2,576		886		68		3,530
Total net sales	$	22,712	$	6,857	$	913	$	30,482

	Three Months Ended September 30, 2024
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration1		Total Net Sales by Market
Medical Device(2)	$	5,505	$	2,087	$	898	$	8,490
Medical Imaging(2)		7,206		2,348		3		9,557
Industrial		5,505		2,667		262		8,434
Aerospace and Defense		4,394		494		38		4,926
Total net sales	$	22,610	$	7,596	$	1,201	$	31,407

	Nine Months Ended September 30, 2025
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration1		Total Net Sales by Market
Medical Device	$	16,579	$	5,738	$	1,654	$	23,971
Medical Imaging		22,413		6,211		17		28,641
Industrial		17,459		5,729		485		23,673
Aerospace and Defense		9,333		2,250		184		11,767
Total net sales	$	65,784	$	19,928	$	2,340	$	88,052

	Nine Months Ended September 30, 2024
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration1		Total Net Sales by Market
Medical Device(2)	$	17,178	$	6,919	$	2,396	$	26,493
Medical Imaging(2)		20,291		7,193		14		27,498
Industrial		18,847		7,682		1,114		27,643
Aerospace and Defense		16,494		1,231		154		17,879
Total net sales	$	72,810	$	23,025	$	3,678	$	99,513

1	Noncash consideration represents material provided by the customer used in the manufacturing of the product.
2	Medical, as reported in the prior-year period filing, has been split between Medical Device and Medical Imaging to conform with the current-year presentation.

SCHEDULE OF CONTRACT ASSETS

Contract assets, recorded in the condensed consolidated balance sheets, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the nine months ended September 30, 2025 were as follows:

Balance as of December 31, 2024	$	13,792
Increase (decrease) attributed to:
Amounts transferred over time to contract assets		65,784
Allowance for current expected credit losses		(1	)
Amounts invoiced during the period		(64,247	)
Balance outstanding as of September 30, 2025	$	15,328